Investigation of PD‑L1 expression and tislelizumab efficacy in gastroesophageal adenocarcinoma using a novel tumor and immune cell score with ventana PD-L1 (SP263) assay and combined positive score (CPS)

 POSTER   09/2020

For more information about this resource, please submit a medical information request.

Rating

Rate this resource